My Publications

Publication Track Record Summary:

  • Number of accepted peer-reviewed manuscripts: 51
  • First author: 7
  • Last author: 23
  • H-index: 20
  • Number of citations: 1591
  • Average impact of journals: 6.5 (new/national journals counted as 0)
  • Average number of citations/paper: 32

 

49. High-molecular-weight kininogen: breaking bad in lethal endotoxemia.
Hofman ZLM, De Maat S, Maas C.
J Thromb Haemost. 2017 Dec 11. doi: 10.1111/jth.13924. [Epub ahead of print] IF=5.3

48. Amplified endogenous plasmin activity resolves acute thrombotic thrombocytopenic purpura in mice
Claudia Tersteeg, Bérangère Joly, Louis Deforche, Ann Gils, Roger Lijnen, Hans Deckmyn, Paul J Declerck, Barbara Plaimauer, Paul Coppo, Agnès Veyradier, Coen Maas, Simon F De Meyer, Karen Vanhoorelbeke
Journal of Thrombosis and Haemostasis 2017 IF=5.3

47. Coagulation factor XII regulates inflammatory responses in human lungs.
Hess R, Wujak L, Hesse C, Sewald K, Jonigk D, Warnecke G, Fieguth HG, de Maat S, Maas C, Bonella F, Preissner KT, Weiss B, Schaefer L, Kuebler WM, Markart P, Wygrecka M.
Thromb Haemost. 2017 Aug 17;117(10). doi: 10.1160/TH16-12-0904. IF=5.7

46. Cleaved Kininogen as a Biomarker for bradykinin release in hereditary angioedema
Zonne L.M. Hofman, Steven de Maat, Chiara Suffritti, Andrea Zanichelli, Cassandra van Doorn, Silvie A.E. Sebastian, Nora Veszeli, Dorottya Csuka, Thomas Renné, Gerard Pasterkamp, Marco Cicardi, Henriette Farkas,C. Erik Hack, Coen Maas.
Journal of Allergy and Clinical Immunology 2017, accepted IF=13.2

45. Live-cell Imaging of Platelet Degranulation and Secretion Under Flow.
Barendrecht AD, Verhoef JJF, Pignatelli S, Pasterkamp G, Heijnen HFG, Maas C.
J Vis Exp. 2017 Jul 10;(125). doi: 10.3791/55658. PMID: 28715386 IF=1.1

44. Hereditary Angioedema with Normal C1 Inhibitor: Update on Evaluation and Treatment.
Magerl M, Germenis AE, Maas C, Maurer M.
Immunol Allergy Clin North Am. 2017 Aug;37(3):571-584. doi: 10.1016/j.iac.2017.04.004. Review. PMID: 28687110 IF=3.6

43. Polyphosphate nanoparticles on the platelet surface trigger contact system activation
Verhoef JJ, Barendrecht AD, Nickel KF, Dijkxhoorn K, Kenne E, Labberton L, McCarty OJ, Schiffelers R, Heijnen HF, Hendrickx AP, Schellekens H, Fens MH, de Maat S, Renne T, Maas C
Blood  Jan 3. pii: blood-2016-08-734988. doi: 10.1182/blood-2016-08-734988. [Epub ahead of print] IF=13.2

42. Anti-histone Properties C1 Esterase Inhibitor Protect Against Lung Injury
Wygrecka M, Kosanovic D, Wujak L, Reppe K, Henneke I, Frey H, Didiasova M, Kwapiszewska G, Marsh LM, Baal N, Hackstein H, Zakrzewicz D, Muller-Redetzky HC, de Maat S, Maas C, Nolte MW, Panousis C, Schermuly RT, Seeger W, Witzenrath M, Schaefer L, Markart P.
Am J Respir Crit Care Med. 2016 Dec 22. doi: 10.1164/rccm.201604-0712OC. IF=13.1

41. Iron nanomedicines induce Toll-Like Receptor activation, cytokine production and complement activation
Verhoef JJ, de Groot AM, van Moorsel M, Ritsema J, Beztsinna N, Maas C, Schellekens H.
Biomaterials 2017 Mar;119:68-77. doi: 10.1016/j.biomaterials.2016.11.025.  IF=8.4

40. Polyphosphate Strikes Back
Maas C
Blood 2016 Dec 15;128(24):2754-2756. IF=11.8

39. A flow cytometry-based assay for procoagulant platelet polyphosphate.
Labberton L, Long AT, Gendler SJ, Snozek C, Stavrou EX, Nickel KF, Maas C, Blankenberg S, Hernandez JS, Renne T.
Cytometry B Clin Cytom. 2016 Nov 4. doi: 10.1002/cyto.b.21492. IF=2.8

38. Processing of Factor XII during Inflammatory Reactions
Jukema B.N., de Maat S., Maas C
Front. Med. 2016 Nov 4;3:52. doi: 10.3389/fmed.2016.00052 (invited) [link] IF=N/A

37. Trombotische trombocytopenische purpura: nieuwe therapeutische ontwikkelingen
Fijnheer R, Voorberg J, Maas C
Nederlands Tijdschrift voor Hematologie (NTvH) 2016;13:18-24 [link] IF=N/A

36. Bradykinin; a link between allergy and inflammation (Bradykinine; een schakel tussen
allergie en ontsteking)
Clark, mw. Z. Hofman, S. de Maat, C. Maas
Nederlands Tijdschrift voor Allergie & Astma (NTvAA) 2016 (accepted, invited article in Dutch)  [link] IF=N/A

35. Neutralizing Blood-borne Polyphosphate In Vivo Provides Safe Thromboprotection
Labberton L, Kenne E, Long AT, Nickel KF, Di Gennaro A, Rigg RA, Hernandez JS, Butler L, Maas C., Stavrou EX, Renne T.
Nature Communications 2016 Sep 6;7:12616. doi: 10.1038/ncomms12616. IF=11.3

34. Factor XII: Form determines Function.
de Maat S,  Maas C.
Journal of Thrombosis and Haemostasis 2016 Jun 10 IF=5.5 de Maat 2016 JTH, uncorrected pre-print version

33. Bradykinin: Inflammatory Product of the Coagulation System
Hofman Z.L.M, de Maat S., Hack C.E., Maas C
Clinical Reviews in Allergy and Immunology 2016 (in Angioedema theme issue; invited) IF=5.5 [link]

32. Plasmin is a natural trigger for bradykinin production in hereditary angioedema with Factor XII mutations
de Maat S, Bjorkqvist J, Suffritti C, Wiesenekker CP, Nagtegaal W, Koekman A, van Dooremalen S, Pasterkamp G, de Groot PG, Cicardi M, Renne T, Maas C.
Journal of Allergy and Clinical Immunology 2016 Nov;138(5):1414-1423.e9. doi: 10.1016/j.jaci.2016.02.021.[Link]  IF=12.5 [de Maat et al JACI 2016 – accepted, uncorrected proofs]

31. Zilberman-Rudenko J, Itakura A, Wiesenekker CP, Vetter R, Maas C, Gailani D, Tucker EI, Gruber A, Gerdes C, McCarty OJ.
Coagulation Factor XI Promotes Distal Platelet Activation and Single Platelet Consumption in the Bloodstream Under Shear Flow.
Arteriosclerosis, thrombosis, and vascular biology 2016 Jan 14. [link] IF=6.0.

30: Keeping von Willebrand Factor under Control: Alternatives for ADAMTS13.
Tersteeg C, Fijnheer R, Pasterkamp G, de Groot PG, Vanhoorelbeke K, de Maat S, Maas C.
Seminars in Thrombosis and Haemostasis 2015 Nov 23. (invited). [link]  IF=3.9.

29: Gerardus PJ Hout, Michel PJ Teuben, Marjolein Heeres, Steven Maat, Renate Jong, Coen Maas, Lisanne HJA Kouwenberg, Leo Koenderman, Wouter W Solinge, Saskia CA Jager, Gerard Pasterkamp, Imo E Hoefer
Invasive surgery reduces infarct size and preserves cardiac function in a porcine model of myocardial infarction
Journal of cellular and molecular medicine 2015; 19 (11), 2655-2663 [link] IF=4.0

28: Jenny Bjorkqvist, Steven de Maat, Urs Lewandrowski, Antonio Di Gennaro, Chris Oschatz, Kai Schonig, Markus M Nothen, Christian Drouet, Hal Braley, Marc W Nolte, Albert Sickmann, Con Panousis, Coen Maas, Thomas Renne
Defective glycosylation of coagulation factor XII underlies hereditary angioedema type III
The Journal of Clinical Investigation 2015; 125 (8), 3132 [link] IF=13.3

27: In Vitro Hemocompatibility Testing of Dyneema Purity Fibers in Blood Contact
Amir Basir, Philip de Groot, Paul F Grundeman, Claudia Tersteeg, Coen Maas, Arjan Barendrecht, Joost van Herwaarden, Jolanda Kluin, Frans Moll, Gerard Pasterkamp, Mark Roest
Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery 2015; 19 (11), 2655-2663 [link] IF*=N/A (new journal)

26: Response to letter regarding article, “plasmin cleavage of von willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy”.
Tersteeg C, de Maat S, De Meyer SF, Smeets MW, Barendrecht AD, Roest M, Pasterkamp G, Fijnheer R, Vanhoorelbeke K, de Groot PG, Maas C
Circulation. 2015 Jan 13;131(2):e19-20. IF*=14.4

25: Sala-Cunill A, Bjorkqvist J, Senter R, Guilarte M, Cardona V, Labrador M, Nickel KF, Butler L, Luengo O,   Kumar P, Labberton L, Long A, Di Gennaro A, Kenne E, Jamsa¤ A, Krieger T, Schluter H, Fuchs T, Flohr S, Hassiepen U, Cumin U, McCrae K, Maas C, Stavrou E, and Renne T
Activation of the plasma contact system in anaphylaxis- insight into severe mast cell-mediated allergic reactions.
Journal of Allergy and Clinical Immunology 2015; 135 (4), 1031-1043. e6 2 [link] IF*=11.5

24: De Angelis V, Koekman A.C, Weeterings C, Roest M, de Groot Ph. G, Herczenik E. and Maas C 
Endocannabinoids control platelet activation and limit aggregate formation under flow”
PLoS ONE 2014 Sep 29;9(9):e108282. [linkIF*=3.2

de Angelis et al. 2014 PLoS ONE

23: de Maat S, de Groot Ph.G. and Maas C
Contact System Activation on Endothelial Cells
Seminars in Thrombosis and Hemostasis. 2014 Nov;40(8):887-94. (invited)  [link] IF*=3.9

22: Flinsenberg TW, Janssen WJ, Herczenik E, Boross P, Nederend M, Jongeneel LH, Scholman RC, Boelens JJ, Maas C, van Gijn ME, van Montfrans JM, Leusen JH, Boes M.
A novel FcgRIIa Q27W gene variant associates with common variable immune deficiency through defective FcgRIIa downstream signalling
Clinical Immunology 2014 Sep 18. pii: S1521-6616(14)00217-4. [link]  IF*=3.7

21: S. de Maat, C. Tersteeg, E. Herczenik, C. Maas
Tracking down contact activation “ from coagulation in vitro to inflammation in vivo
International Journal of Laboratory Hematology, 36 (3), 374-381 (invited) [link] IF*=1.8

de Maat et al. 2014 Int J Lab Hematol

20: Tersteeg C, de Maat S, De Meyer SF, Smeets MW, Barendrecht AD, Roest M, Pasterkamp G, Fijnheer R, Vanhoorelbeke K, de Groot PG, Maas C.
Plasmin Cleavage of von Willebrand Factor as an Emergency Bypass for ADAMTS13 Deficiency in Thrombotic Microangiopathy
Circulation 2014 March 25, 129: 1320-13331. PMID: 24449821 [link] IF*=15.2

Tersteeg et al. 2014 Circulation

Editorial by Anil K. Chauhan: Degradation of Platelet-VWF Complexes by Plasmin: An Alternative/Backup Mechanism to ADAMTS13 [link]

19: Tersteeg C, Heijnen HF, Eckly A, Pasterkamp G, Urbanus RT, Maas C, Hoefer IE, Nieuwland R, Farndale RW, Gachet C, de Groot PG, Roest M.
FLow-Induced PRotrusions (FLIPRs): A Platelet-Derived Platform for the Retrieval of Microparticles by Monocytes and Neutrophils. Circ Res. 2014 Jan 9. [Epub ahead of print] PubMed PMID: 24406984. [link]  IF*=11.9

18: Du VX, Huskens D, Maas C, Al Dieri R, de Groot PG, de Laat B.
New Insights into the Role of Erythrocytes in Thrombus Formation.
Semin Thromb Hemost. 2014 Feb 40(1):72-80. [Epub ahead of print] PubMed PMID: 24356930. [link]  IF*=4.2

17: Maas C.
The Protease Storm of Angioedema
Journal of Angioedema 2013. 1 (2), 18-27 (invited) [link] IF=N/A (new journal)

Maas 2013 Journal of Angioedema

16: Bjorkqvist J, Lecher B, Maas C, Renne T.
Zinc-dependent contact system activation induces vascular leakage and hypotension in rodents.
Biol Chem. 2013 Sep;394(9):1195-204. doi: 10.1515/hsz-2013-0144. PubMed PMID: 23640941. [link]  IF*=3.0

Bjorkqvist et al. 2013 Biol. Chem.

15: Steller EJ, Raats DA, Koster J, Rutten B, Govaert KM, Emmink BL, Snoeren N, van Hooff SR, Holstege FC, Maas C, Borel Rinkes IH, Kranenburg O.
PDGFRB promotes liver metastasis formation of mesenchymal-like colorectal tumor cells.
Neoplasia. 2013 Feb;15(2):204-17. PubMed PMID: 23441134; PubMed Central PMCID: PMC3579322. [link] IF*=6.0

14: de Maat S, van Dooremalen S, de Groot PG, Maas C.
A nanobody-based method for tracking factor XII activation in plasma.
Thromb Haemost. 2013 Sep;110(3):458-68. doi: 10.1160/TH12-11-0792. Epub 2013 Jan 24. PubMed PMID: 23349032. [link] IF*=6.1

de Maat et al. 2013 Thromb. Haemost.

13: Renne T, Schmaier AH, Nickel KF, Blomback M, Maas C.
In vivo roles of factor XII.
Blood. 2012 Nov 22;120(22):4296-303. doi: 10.1182/blood-2012-07-292094. Epub 2012 Sep 19. PubMed PMID: 22993391; PubMed Central PMCID: PMC3507141. [link] IF*=9.2

Renne et al. 2012 Blood

12: de Groot Ph.G., Roest M., Heijnen H.F., Maas C., Urbanus R.T.
Investigations into the hemostatic response
Ned Tijdschr Klin Chem Labgeneesk [link]  IF*=0

11: Maas C, Renne T.
Regulatory mechanisms of the plasma contact system.
Thromb Res. 2012 May;129 Suppl 2:S73-6. doi: 10.1016/j.thromres.2012.02.039. Epub 2012 Mar 6. Review. PubMed PMID: 22398015. [link] IF*=3.1

Maas et al. 2012 Thromb. Res.

10: de Laat B, van Berkel M, Urbanus RT, Siregar B, de Groot PG, Gebbink MF, Maas C.
Immune responses against domain I of Beta(2)-glycoprotein I are driven by conformational changes: domain I of Beta(2)-glycoprotein I harbors a cryptic immunogenic epitope.
Arthritis Rheum. 2011 Dec;63(12):3960-8. doi:10.1002/art.30633. PubMed PMID: 21898342. [link] IF*=7.8

de Laat et al. 2011 Arthritis Rheum.

9: Maas C, Oschatz C, Renne T.
The plasma contact system 2.0.
Semin Thromb Hemost. 2011 Jun;37(4):375-81. doi: 10.1055/s-0031-1276586. Epub 2011 Jul 30. Review. PubMed PMID: 21805443. [link] IF*=4.5

8: Oschatz C, Maas C, Lecher B, Jansen T, Bjorkqvist J, Tradler T, Sedlmeier R, Burfeind P, Cichon S, Hammerschmidt S, Muller-Esterl W, Wuillemin WA, Nilsson G, Renne T.
Mast cells increase vascular permeability by heparin-initiated bradykinin formation in vivo.
Immunity. 2011 Feb 25;34(2):258-68. doi: 10.1016/j.immuni.2011.02.008. PubMed PMID: 21349432. [link] IF*=21.6

Oschatz et al. 2011 Immunity

7: Maas C, Meijers JC, Marquart JA, Bakhtiari K, Weeterings C, de Groot PG, Urbanus RT.
Activated factor V is a cofactor for the activation of factor XI by thrombin in plasma.
Proc Natl Acad Sci U S A. 2010 May 18;107(20):9083-7. doi:10.1073/pnas.1004741107. Epub 2010 May 3. PubMed PMID: 20439754; PubMed Central PMCID: PMC2889092. [link] IF*=9.7

Maas et al. Proc. Natl. Acad. Sci. U.S.A.

6: Gebbink MF, Bouma B, Maas C, Bouma BN.
Physiological responses to protein aggregates: fibrinolysis, coagulation and inflammation (new roles for old factors).
FEBS Lett. 2009 Aug 20;583(16):2691-9. doi: 10.1016/j.febslet.2009.06.013. Epub 2009 Jun 13. Review. PubMed PMID: 19527723. [link] IF*=3.0

Gebbink et al. 2009 FEBS Lett.

5: Maas C, Schiks B, Strangi RD, Hackeng TM, Bouma BN, Gebbink MF, Bouma B.
Identification of fibronectin type I domains as amyloid-binding modules on tissue-type plasminogen activator and three homologs.
Amyloid. 2008 Sep;15(3):166-80. doi: 10.1080/13506120802193498. PubMed PMID: 18925455. [link] IF*=1.7

Maas et al. 2008 Amyloid

4: Maas C, Govers-Riemslag JW, Bouma B, Schiks B, Hazenberg BP, Lokhorst HM,
Hammarstrom P, ten Cate H, de Groot PG, Bouma BN, Gebbink MF.
Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation.
J Clin Invest. 2008 Sep;118(9):3208-18. doi: 10.1172/JCI35424. PubMed PMID: 18725990; PubMed Central PMCID: PMC2518075. [link] IF*=16.6

Maas et al. 2008 J. Clin. Invest.

Commentary by Alvin H. Schmaier: The elusive physiological role of Factor XII [link]

3: Bouma B*, Maas C*, Hazenberg BP, Lokhorst HM, Gebbink MF.  *contributed equally.
Increased plasmin-alpha2-antiplasmin levels indicate activation of the fibrinolytic system in systemic amyloidoses.
J Thromb Haemost. 2007 Jun;5(6):1139-42. Epub 2007 Feb 20. PubMed PMID: 17371485. [link]  IF*=5.9

Bouma et al. 2007 J. Thromb. Haemost.

Commentary by Per Hammarstrm: The bloody path of amyloids and prions [link]

2: Maas C, Hermeling S, Bouma B, Jiskoot W, Gebbink MF.
A role for protein misfolding in immunogenicity of biopharmaceuticals.
J Biol Chem. 2007 Jan 26;282(4):2229-36. Epub 2006 Nov 29. PubMed PMID: 17135263. [link]  IF*=5.7

Maas et al. 2007 J. Biol. Chem.

1: Hermeling S, Schellekens H, Maas C, Gebbink MF, Crommelin DJ, Jiskoot W.
Antibody response to aggregated human interferon alpha2b in wild-type and transgenic immune tolerant mice depends on type and level of aggregation.
J Pharm Sci. 2006 May;95(5):1084-96. PubMed PMID: 16552750. [link] IF*=2.9

Hermeling et al. J Pharm Sci

 

* Impact factors of the journals are provided as they were at the moment of publication